These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20842112)

  • 1. Wilms' tumour 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways.
    Sitaram RT; Degerman S; Ljungberg B; Andersson E; Oji Y; Sugiyama H; Roos G; Li A
    Br J Cancer; 2010 Oct; 103(8):1255-62. PubMed ID: 20842112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma.
    Sitaram RT; Cairney CJ; Grabowski P; Keith WN; Hallberg B; Ljungberg B; Roos G
    Int J Cancer; 2009 Aug; 125(4):783-90. PubMed ID: 19384955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Wilms' tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene.
    Oh S; Song Y; Yim J; Kim TK
    J Biol Chem; 1999 Dec; 274(52):37473-8. PubMed ID: 10601322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues.
    Fan Y; Liu Z; Fang X; Ge Z; Ge N; Jia Y; Sun P; Lou F; Björkholm M; Gruber A; Ekman P; Xu D
    Clin Cancer Res; 2005 Jun; 11(12):4331-7. PubMed ID: 15958614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The opposing effect of hypoxia-inducible factor-2alpha on expression of telomerase reverse transcriptase.
    Lou F; Chen X; Jalink M; Zhu Q; Ge N; Zhao S; Fang X; Fan Y; Björkholm M; Liu Z; Xu D
    Mol Cancer Res; 2007 Aug; 5(8):793-800. PubMed ID: 17699105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic utility of Wilms' tumour-1 protein (WT-1) immunostaining in paediatric renal tumours.
    Goyal S; Mishra K; Sarkar U; Sharma S; Kumari A
    Indian J Med Res; 2016 May; 143(Supplement):S59-S67. PubMed ID: 27748279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wilms' tumor protein induces an epithelial-mesenchymal hybrid differentiation state in clear cell renal cell carcinoma.
    Sampson VB; David JM; Puig I; Patil PU; de Herreros AG; Thomas GV; Rajasekaran AK
    PLoS One; 2014; 9(7):e102041. PubMed ID: 25025131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of human telomerase reverse transcriptase in hepatocellular carcinoma.
    Chen CJ; Kyo S; Liu YC; Cheng YL; Hsieh CB; Chan DC; Yu JC; Harn HJ
    World J Gastroenterol; 2004 Mar; 10(5):638-42. PubMed ID: 14991929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
    Han Y; San-Marina S; Yang L; Khoury H; Minden MD
    Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.
    Vidovic K; Svensson E; Nilsson B; Thuresson B; Olofsson T; Lennartsson A; Gullberg U
    Leukemia; 2010 May; 24(5):992-1000. PubMed ID: 20237505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells.
    Deng WG; Jayachandran G; Wu G; Xu K; Roth JA; Ji L
    J Biol Chem; 2007 Sep; 282(36):26460-70. PubMed ID: 17630431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of epigenetic states by WT1 via regulation of de novo DNA methyltransferase 3A.
    Szemes M; Dallosso AR; Melegh Z; Curry T; Li Y; Rivers C; Uney J; Mägdefrau AS; Schwiderski K; Park JH; Brown KW; Shandilya J; Roberts SG; Malik K
    Hum Mol Genet; 2013 Jan; 22(1):74-83. PubMed ID: 23042785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation by the Wilms' tumour suppressor protein WT1.
    Wagner KJ; Roberts SG
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):932-5. PubMed ID: 15506928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors.
    Li CM; Kim CE; Margolin AA; Guo M; Zhu J; Mason JM; Hensle TW; Murty VV; Grundy PE; Fearon ER; D'Agati V; Licht JD; Tycko B
    Am J Pathol; 2004 Dec; 165(6):1943-53. PubMed ID: 15579438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of proliferation and induction of apoptosis in human renal carcinoma cells by anti-telomerase small interfering RNAs.
    Zheng JN; Sun YF; Pei DS; Liu JJ; Chen JC; Li W; Sun XQ; Shi QD; Han RF; Ma TX
    Acta Biochim Biophys Sin (Shanghai); 2006 Jul; 38(7):500-6. PubMed ID: 16820866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
    Chen R; Zhu J; Dong Y; He C; Hu X
    Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors.
    Udtha M; Lee SJ; Alam R; Coombes K; Huff V
    Oncogene; 2003 Jun; 22(24):3821-6. PubMed ID: 12802290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wilms' tumor protein (-KTS) modulates renin gene transcription.
    Steege A; Fähling M; Paliege A; Bondke A; Kirschner KM; Martinka P; Kaps C; Patzak A; Persson PB; Thiele BJ; Scholz H; Mrowka R
    Kidney Int; 2008 Aug; 74(4):458-66. PubMed ID: 18496514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of ceramide-mediated telomerase inhibition in the A549 human lung adenocarcinoma cell line.
    Ogretmen B; Kraveka JM; Schady D; Usta J; Hannun YA; Obeid LM
    J Biol Chem; 2001 Aug; 276(35):32506-14. PubMed ID: 11441001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early growth response-1 mediates downregulation of telomerase in cervical cancer.
    Akutagawa O; Nishi H; Kyo S; Terauchi F; Yamazawa K; Higuma C; Inoue M; Isaka K
    Cancer Sci; 2008 Jul; 99(7):1401-6. PubMed ID: 18460021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.